Rezolute (RZLT) Competitors $3.60 -0.14 (-3.74%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$3.60 +0.00 (+0.14%) As of 03/14/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RZLT vs. REPL, BCAX, DAWN, EOLS, CDMO, PRTA, COGT, PHVS, ZYME, and AVXLShould you be buying Rezolute stock or one of its competitors? The main competitors of Rezolute include Replimune Group (REPL), Bicara Therapeutics (BCAX), Day One Biopharmaceuticals (DAWN), Evolus (EOLS), Avid Bioservices (CDMO), Prothena (PRTA), Cogent Biosciences (COGT), Pharvaris (PHVS), Zymeworks (ZYME), and Anavex Life Sciences (AVXL). These companies are all part of the "pharmaceutical products" industry. Rezolute vs. Replimune Group Bicara Therapeutics Day One Biopharmaceuticals Evolus Avid Bioservices Prothena Cogent Biosciences Pharvaris Zymeworks Anavex Life Sciences Rezolute (NASDAQ:RZLT) and Replimune Group (NASDAQ:REPL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, community ranking, risk, analyst recommendations, valuation, earnings and institutional ownership. Does the media favor RZLT or REPL? In the previous week, Rezolute had 2 more articles in the media than Replimune Group. MarketBeat recorded 4 mentions for Rezolute and 2 mentions for Replimune Group. Replimune Group's average media sentiment score of 0.85 beat Rezolute's score of 0.22 indicating that Replimune Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rezolute 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Replimune Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer RZLT or REPL? Replimune Group received 97 more outperform votes than Rezolute when rated by MarketBeat users. However, 80.00% of users gave Rezolute an outperform vote while only 64.02% of users gave Replimune Group an outperform vote. CompanyUnderperformOutperformRezoluteOutperform Votes7280.00% Underperform Votes1820.00% Replimune GroupOutperform Votes16964.02% Underperform Votes9535.98% Is RZLT or REPL more profitable? Replimune Group's return on equity of -54.84% beat Rezolute's return on equity.Company Net Margins Return on Equity Return on Assets RezoluteN/A -70.27% -62.41% Replimune Group N/A -54.84%-42.97% Do institutionals & insiders have more ownership in RZLT or REPL? 83.0% of Rezolute shares are owned by institutional investors. Comparatively, 92.5% of Replimune Group shares are owned by institutional investors. 18.4% of Rezolute shares are owned by company insiders. Comparatively, 8.8% of Replimune Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has preferable valuation and earnings, RZLT or REPL? Replimune Group is trading at a lower price-to-earnings ratio than Rezolute, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRezoluteN/AN/A-$68.46M-$1.22-2.95Replimune GroupN/AN/A-$215.79M-$3.07-3.79 Which has more volatility & risk, RZLT or REPL? Rezolute has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Comparatively, Replimune Group has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Do analysts prefer RZLT or REPL? Rezolute presently has a consensus target price of $24.38, suggesting a potential upside of 577.08%. Replimune Group has a consensus target price of $19.43, suggesting a potential upside of 66.77%. Given Rezolute's higher probable upside, equities analysts plainly believe Rezolute is more favorable than Replimune Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rezolute 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Replimune Group 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 SummaryRezolute beats Replimune Group on 7 of the 13 factors compared between the two stocks. Remove Ads Get Rezolute News Delivered to You Automatically Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RZLT vs. The Competition Export to ExcelMetricRezolutePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$226.40M$7.03B$5.67B$8.13BDividend YieldN/A2.74%4.40%4.08%P/E Ratio-2.956.2623.7519.03Price / SalesN/A232.37393.8987.83Price / CashN/A65.6738.0534.64Price / Book2.186.596.834.29Net Income-$68.46M$142.18M$3.19B$247.30M7 Day Performance-6.49%-1.28%6.55%-0.87%1 Month Performance-21.91%-8.96%-0.36%-9.36%1 Year Performance102.25%-6.24%11.95%3.93% Rezolute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RZLTRezolute2.5646 of 5 stars$3.60-3.7%$24.38+577.1%+97.8%$226.40MN/A-2.9540Short Interest ↑REPLReplimune Group3.8187 of 5 stars$11.14-3.2%$19.43+74.4%+31.8%$857.95MN/A-3.63210BCAXBicara TherapeuticsN/A$15.36-7.2%$41.20+168.2%N/A$835.83MN/A0.0032Upcoming EarningsAnalyst ForecastLockup ExpirationNews CoverageDAWNDay One Biopharmaceuticals2.5815 of 5 stars$8.07-6.9%$34.57+328.4%-42.8%$817.94M$131.16M-7.8360EOLSEvolus3.8359 of 5 stars$12.68-6.6%$24.67+94.5%-6.2%$806.28M$266.27M-13.93170Insider TradeHigh Trading VolumeCDMOAvid Bioservices1.0024 of 5 stars$12.50+0.1%$12.25-2.0%+105.2%$799.18M$139.91M-5.23320High Trading VolumePRTAProthena3.2811 of 5 stars$14.60-4.4%$55.00+276.7%-48.1%$785.87M$135.16M-6.35130Analyst RevisionPositive NewsCOGTCogent Biosciences2.3434 of 5 stars$6.85-2.3%$14.43+110.6%+9.2%$779.87MN/A-2.7680PHVSPharvaris1.6023 of 5 stars$14.90-0.7%$40.50+171.8%-29.6%$779.12MN/A-5.3230Short Interest ↑ZYMEZymeworks3.3549 of 5 stars$11.10-7.5%$19.50+75.7%+13.7%$772.31M$76.30M-7.40460Analyst ForecastInsider TradeAnalyst RevisionNews CoverageGap UpHigh Trading VolumeAVXLAnavex Life Sciences3.9931 of 5 stars$8.99+3.7%$44.00+389.4%+83.5%$764.73MN/A-16.3540Positive News Remove Ads Related Companies and Tools Related Companies REPL Alternatives BCAX Alternatives DAWN Alternatives EOLS Alternatives CDMO Alternatives PRTA Alternatives COGT Alternatives PHVS Alternatives ZYME Alternatives AVXL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RZLT) was last updated on 3/15/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rezolute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rezolute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
